Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran

Author(s):
Masoumeh Amin-EsmaeiliMasoumeh Amin-Esmaeili1, Masoumeh Amin-EsmaeiliMasoumeh Amin-Esmaeili1, Afarin Rahimi-MovagharAfarin Rahimi-MovagharAfarin Rahimi-Movaghar ORCID1,*, Afarin Rahimi-MovagharAfarin Rahimi-MovagharAfarin Rahimi-Movaghar ORCID2,*, Emran M. RazaghiEmran M. Razaghi1, Emran M. RazaghiEmran M. Razaghi2, Ahmad Reza BaghestaniAhmad Reza Baghestani1, Ahmad Reza BaghestaniAhmad Reza Baghestani3, Siavash JafariSiavash Jafari3, Siavash JafariSiavash Jafari4
1Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, IR Iran
2Psychiatry Department, Tehran University of Medical Sciences, Tehran, IR Iran
3Islamic Azad University, South Tehran Branch, Tehran, IR Iran
4Faculty of Medicine, School of Population and Public Health, The University of British Columbia, Vancouver, Canada
Corresponding Authors:
*Corresponding author at: Afarin Rahimi-Movaghar, Iranian Research Center for HIV/AIDS, Imam Khomeini Hospital, Keshavarz Blv., P.O. Box: 14197-33141, Tehran, IR Iran. Tel.: +98-2166947984, Fax: +98-2166947984, E-mail:, [email protected]. Email: [email protected]
*Corresponding author at: Afarin Rahimi-Movaghar, Iranian Research Center for HIV/AIDS, Imam Khomeini Hospital, Keshavarz Blv., P.O. Box: 14197-33141, Tehran, IR Iran. Tel.: +98-2166947984, Fax: +98-2166947984, E-mail:, [email protected]. Email: [email protected]

Hepatitis Monthly:Vol. 12, issue 1; 23-31
Published online:Dec 31, 2011
Article type:Research Article
Received:Oct 08, 2011
Accepted:Jan 02, 2012
How to Cite:Amin-Esmaeili M, Amin-Esmaeili M, Rahimi-Movaghar A, Rahimi-Movaghar A, Razaghi E, et al. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon. 2011;12(1):. doi: https://doi.org/10.5812/kowsar.1735143X.806

Abstract

Background:

In Iran, the number of injecting drug users (IDUs) has increased in recent years. The rates of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections among IDUs are reportedly high.

Objectives:

The purpose of this study was to assess factors correlated with HCV and HBV infections among IDUs in Tehran.

Patients and Methods:

A cross-sectional study included 899 IDUs recruited from the community, drug treatment centers, and drop-in-centers. The study involved interviews conducted using an adapted version of the WHO Drug Injection Study Phase II (Version 2b) questionnaire and blood testing for the HCV antibody, hepatitis B surface antigen, and hepatitis B core antibody. A logistic regression model was used to identify independent factors correlated with HCV and HBV infections.

Results:

HCV infection was found to be primarily associated with female gender [odds ratio (OR) 5.0, 95% confidence interval (CI) 2.0-10.0)], unmarried status (OR 2.9, 95% CI 1.9-4.4), drug use for more than 10 years (OR 2.7, 95% CI 1.8-3.9), drug injection frequency of more than once per day (OR 2.6, 95% CI 1.6-4.2), history of imprisonment (OR 2.5, 95% CI 1.6-4.0)], and a history of shared injection needles in prison (OR 2.3, 95% CI 1.5-3.6). HBV infection was mainly correlated with a history of imprisonment (OR 1.9, 95% CI 1.4-2.7) and drug use for more than 10 years (OR 1.4, 95% CI 1.1-1.9).

Conclusions:

Because a considerable number of IDUs in Iran are receiving reduction services, tailoring services for prevention of hepatitis infection are necessary.

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Mar
2008

Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002)

Hamid Tavakkoli,
Mohammad Mahdi Mir-Nasseri,
Hossein Poustchi,
Parviz Afshar,
Mohammad Nabi Motalebi,
Ashraf Mohammadkhani
,et al.

Tavakkoli H, Mir-Nasseri M, Poustchi H, Afshar P, Motalebi M, et al. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002). Hepat Mon. 2008;8(1):. doi:

30
Jun
2010

Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006)

Seyed Mohammad Alavi,
Fatemeh Behdad

Alavi S, Behdad F. Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006). Hepat Mon. 2010;10(2):. doi:

25
Oct
2017

Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

Asaad Sharhani,
Yadollah Mehrabi,
Alireza Noroozi,
Maryam Nasirian,
Peter Higgs,
Ahmad Hajebi
,et al.

Sharhani A, Mehrabi Y, Noroozi A, Nasirian M, Higgs P, et al. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran. Hepat Mon. 2017;17(10):e58739. doi: https://doi.org/10.5812/hepatmon.58739

8
Aug
2022
Hepat Mon

Epidemiology of Hepatitis C Virus Infection Among High-risk Populations in Northeastern Iran

Mohammad Reza Hedayati-Moghaddam,
Majid Danaee,
Hossein Soltanian,
Seyed Ahmad Vahedi,
Arman Mosavat,
Maryam Shahi
,et al.

Hedayati-Moghaddam MR, Danaee M, Soltanian H, Vahedi SA, Mosavat A, et al. Epidemiology of Hepatitis C Virus Infection Among High-risk Populations in Northeastern Iran. Hepat Mon. 2022;22(1):e127166. doi: https://doi.org/10.5812/hepatmon-127166

3
Sep
2018
Prevalence and Risk Factors for Occult Hepatitis B and HIV Infections Among HCV Infected Intravenous Drug Users, Tehran, Iran

Prevalence and Risk Factors for Occult Hepatitis B and HIV Infections Among HCV Infected Intravenous Drug Users, Tehran, Iran

Behnoosh Eshraghi Mosa Abadi,
Tahmineh Kandelouei,
Gita Eslami,
Maryam Asli,
Maryam Vaezjalali

Eshraghi Mosa Abadi B, Kandelouei T, Eslami G, Asli M, Vaezjalali M. Prevalence and Risk Factors for Occult Hepatitis B and HIV Infections Among HCV Infected Intravenous Drug Users, Tehran, Iran. Arch Clin Infect Dis. 2018;13(6):e67968. doi: https://doi.org/10.5812/archcid.3075

Download PDF325.28 KB

Crossmark

Crossmark

Checking

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles